Synthesis, radiolabelling and biological characterization of (D)-7-iodo-N-(1-phosphonoethyl)-5-aminomethylquinoxaline-2,3-dione, a glycine-binding site antagonist of NMDA receptors

Citation
Sm. Ametamey et al., Synthesis, radiolabelling and biological characterization of (D)-7-iodo-N-(1-phosphonoethyl)-5-aminomethylquinoxaline-2,3-dione, a glycine-binding site antagonist of NMDA receptors, BIOORG MED, 10(1), 2000, pp. 75-78
Citations number
19
Categorie Soggetti
Chemistry & Analysis
Journal title
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
ISSN journal
0960894X → ACNP
Volume
10
Issue
1
Year of publication
2000
Pages
75 - 78
Database
ISI
SICI code
0960-894X(20000103)10:1<75:SRABCO>2.0.ZU;2-T
Abstract
(D)-7-Iodo-N-(1-phosphonoethyl)-5-aminomethylquinoxaline-2,3-dione (I-PAMQX ), is a potent, in vivo active antagonist acting at the glycine binding sit e of the NMDA receptor complex. Radioiodinated [I-131]I-PAMQX was prepared with good yields and high specific activity from its 7-bromo analogue. Biod istribution studies of [I-131]I-PAMQX in mice showed a relatively slow clea rance from the blood. The uptake of radioactivity was highest in the kidney s, moderate in the heart, lung, liver and bones, and low in the brain. (C) 1999 Elsevier Science Ltd. All rights reserved.